Post-infusion observation of patients with multiple sclerosis receiving natalizumab: Is it necessary?

Multiple Sclerosis and Related Disorders 2026

View at publisher
Authors: Melika Arab Bafrani, Negar Sadat Ahmadi, Fatemeh Zahra Idjadi, Sanaz Bordbar, Shima Jahani, Rayhane Montazeri, Sara Kamali Zonouzi, Mahsa Mohammadi Lapevandani, Zahra Ebadi, Samira Navardi, Hora Heidari, Amirreza Azimi
+2 more Abdorreza Naser Moghadasi, Mohammad Ali Sahraian
DOI: 10.1016/j.msard.2026.106995
Cited by: 0
References: 26

Fields of Study & Subjects

Multiple Sclerosis Research Studies Pharmacovigilance and Adverse Drug Reactions Drug-Induced Adverse Reactions

Publication details

Journal / source
Multiple Sclerosis and Related Disorders
Volume
107
Pages
106995–106995
Publication date
13 January 2026
Language
EN